Conferences & Events News Channel

eyeforpharma The Marketing Disruption Summit

2 - 3 October 2019, Philadelphia, USA.
It's 2019 and Marketing is changing. Your customers' expectations have shifted to ‘one-click’. They expect more, they’re used to intuitive consumer interactions, and now they're looking at pharma.

Providing the seamless, personalized experience you've been dreaming about has never seemed closer. But marketers can't do it alone.

Optima to host post-conference workshop at Lyophilization USA

23 - 24 October 2019, Boston, USA.
Delegates for the 5th Annual Lyophilization USA conference, taking place in Boston, will have the opportunity to attend the half-day post-conference workshop titled "Current and Future Freeze-Drying Technologies and Methods" led by Dena Flamm and Alexander Tambovzev on October 25th 2019.

The need for a blueprint emergency plan to avoid a HPAPI crisis

21 - 22 October 2019, Boston, USA.
With a massive growth within the HPAPI market, manufacturers cannot afford to be complacent in terms of staff training, utilization of approved technology and blueprint accident plans. Straying away from the correct procedures can have a massive affect on your business and industry.

Ophthalmic Drugs Conference 2019

19 - 20 November 2019, London, UK.
The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.

Lyophilization USA Conference 2019

23 - 24 October 2019, Boston, USA.
The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution.

Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference

21 - 22 October 2019, Boston, USA.
The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones.

Wearable Injectors and Connected Devices Conference 2019

9 - 10 October 2019, London, UK.
SMi is proud to present the inaugural Wearable Injectors and Connected Devices Conference, taking place in London. The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.

Conferences & Events News

eyeforpharma The Marketing Disruption Summit

Optima to host post-conference workshop at Lyophilization USA

The need for a blueprint emergency plan to avoid a HPAPI crisis

Ophthalmic Drugs Conference 2019

Lyophilization USA Conference 2019

Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference

Wearable Injectors and Connected Devices Conference 2019

More Pharma News ...

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs